NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-223-2006-1-US-01 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS US CIP 12/291,932 Abandoned
NCI E-019-2009-0-US-01 Human Herpesvirus 6A (HHV6A) Quantitative Real-Time PCR Array US 61/114,753 Abandoned
NCI E-248-2005-0-PCT-02 NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYMERS, COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF PCT PCT PCT/US08/83375 Abandoned
NIAID E-146-2008-1-US-01 Induction Of Profliferation, Molecule Expression And Cytolytic Capacity Of HIV -Specific CD8 + T Cells US 61/199,126 Abandoned
NHGRI E-272-2008-0-US-01 USE OF ERBB4 AS A PROGNOSTIC MARKER FOR MELANOMA US 61/199,156 Abandoned
NCI E-137-2006-1-US-01 Manganese Superoxide Dismutase VAL16ALA Polymorphism Predicts Resistance to Chemotherapeutic Drug Cancer Therapy US National Stage 12/268,655 7985561 Abandoned PDF
NCI E-189-2002-0-US-07 POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND... US DIV 12/268,855 7928096 Abandoned PDF
NIAID E-003-2005-0-US-03 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells US National Stage 11/918,711 9072716 Issued PDF
NCI E-012-2008-0-PCT-02 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV PCT PCT PCT/US2008/012663 Expired
NIAID E-275-2000-3-US-07 Modifications Of HIV Enhance Immunogenicity For Genetic Immunization US DIV 12/291,533 Abandoned
NCI E-012-2008-0-EP-05 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV EP National Stage 885078.1 Abandoned
NCI E-012-2008-0-EP-04 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV EP National Stage 08850780.1 Abandoned
NCI E-024-2009-0-US-01 Molecular Prediction Of Survival Outcome Of Human Hepatocellular Carcinoma (HCC) Patients By A 'driver'-gene-signature. US 61/198,813 Abandoned
NICHD E-339-2008-1-US-01 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. US 61/112,527 Abandoned
NIAID E-238-2008-1-US-01 Device For Microwave-assisted Cryo-sample Processing US 61/112,575 Abandoned
NIDCR E-003-1999-0-US-19 Nucleic Acids Encoding a G-protein Coupled Receptor Involved in Taste Transduction. US CON 12/266,419 Abandoned
NCI E-316-2007-0-PCT-02 METHOD OF INHIBITING ABCG2 AND RELATED TREATMENTS PCT PCT PCT/US2008/082414 Expired
NINDS E-251-2005-0-HK-08 A Device for Volitional Swallowing with a Substitute Sensory System HK National Stage 08112281.5 Abandoned
NCI E-336-2005-0-NZ-12 ANTIBODY COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE NZ National Stage 572559 Abandoned
NCI E-328-2007-0-PCT-02 Identification of Subjects Likely to Benefit from Statin Therapy PCT PCT PCT/US2008/082359 Expired
NIAID E-275-2008-1-US-01 Use Of Mono-Anine Oxidase Inhibitors To Prevent Herpes Simpex Virus Infection And Reactiviation From Latency US 61/111,019 Abandoned
NICHD E-273-2007-0-US-02 Method and Apparatus For Estimating the Elliptical Cone Of Uncertainity US ORD 12/263,569 7906965 Abandoned PDF
NCI E-097-2004-1-US-02 Layered Peptide/antigen Arrays US CON 12/289,736 Abandoned
NHGRI E-273-2008-0-US-01 USE OF MATRIX METALLOPROTEINASE (MMP)-8 AS A PROGNOSTIC MARKER FOR MELANOMA US 61/198,384 Abandoned
NIDCR E-012-2009-0-US-01 Cell-based Assay To Screen Regulators Of Cyclin-dependent Kinase 5 (Cdk5/P35) Kinase Activity08 US 61/198,246 Abandoned
NHLBI E-099-2008-0-PCT-02 Tandem L2 Fusion Vaccines For Prevention Of Human Papillomavirus Infection PCT PCT PCT/US08/082290 Expired
NIDA E-230-2007-0-PCT-02 Unnatural Opioid Enantiomers As Drugs For Treatment Of Pain PCT PCT PCT/US08/01860 Expired
NIDA E-076-2016-0-PCT-02 TLR MODULATORS AND METHODS FOR USING THE SAME PCT PCT PCT/US2008/081862 Expired
NINDS E-133-2006-1-CN-07 Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses CN National Stage 200780015589.0 Abandoned
NIDA E-077-2016-0-PCT-02 TRICYCLIC COMPOUNDS AND METHODS FOR USING THE SAME PCT PCT PCT/US08/081858 Expired
NCI E-029-2008-2-PCT-01 HPV Infection Interrupts Expression Of Cellular Tumor Suppressive MiR-3a PCT PCT COMB PCT/US2008/081434 Abandoned
NCI E-186-2006-0-US-06 Diazeniumdiolated Non-Steroidal Anti-Inflammatory Drugs, Compositions Thereof, And Related Methods US National Stage 12/298,322 Abandoned
NIDCR E-229-2004-0-US-09 Mammalian T1R3 Sweet Taste Receptors US CON 12/257,290 7939279 Expired PDF
NIAID E-031-2004-4-US-02 Anti-Tubercular Drug: Compositions And Methods US CIP 12/255,976 8202910 Expired PDF
NIDCR E-042-2007-0-PCT-02 Bone Scaffolds, Injectable Bone Repair Materials and Methods for Bone Repair PCT PCT PCT/US2008/012064 Expired
NCI E-282-2007-0-PCT-02 Transforming Growth Factor-beta Gene Expression Signature Predicts Clinical Outcome In Cancer PCT PCT PCT/US2008/80802 Abandoned
NCI E-033-2008-0-CA-04 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER CA National Stage 2705488 Issued
NCI E-033-2008-0-EP-05 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER EP National Stage 08850046.7 Issued
NCI E-033-2008-0-AU-03 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER AU National Stage 2008321253 Issued
NCI E-033-2008-0-PCT-02 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER PCT PCT PCT/US2008/080648 Expired
NIDDK E-284-2008-0-AU-02 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists AU National Stage 2008363295 Issued
NIDDK E-284-2008-0-JP-06 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists JP National Stage 2011-532048 Issued
NIDDK E-284-2008-0-EP-04 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists EP National Stage 08876356.0 Issued
NIDDK E-284-2008-0-FR-12 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists FR EP 08876356.0 Issued
NIDDK E-284-2008-0-DE-11 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists DE EP 08876356.0 Issued
NIDDK E-284-2008-0-GB-13 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists GB EP 08876356.0 Issued
NIAID E-293-1999-0-US-30 Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors US DIV 12/288,482 8791074 Abandoned PDF
NIDDK E-284-2008-0-PCT-01 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists PCT PCT PCT/US2008/011958 Expired
NCI E-002-2002-1-US-04 Material And Methods For Inhibiting WIP-1 US DIV 12/254,513 Abandoned
NIDDK E-284-2008-0-CA-03 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists CA National Stage 2741030 Abandoned